SCHEMBL7142641

SCHEMBL7142641

COc1cc(NC(=O)OC(C)(C)C)c(N)cc1-c1ccc(F)cc1C

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AAK1 Q2M2I8 4/20 0.43
ABCB1 P08183 1/20 0.37
ABCC1 P33527 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
CYP1A2 P05177 1/20 0.37
CYP3A4 P08684 1/20 0.37
CYP2C19 P33261 1/20 0.37
HDAC1 Q13547 3/20 0.36
MAPT P10636 2/20 0.36
KMT2A Q03164 2/20 0.36
ALDH1A1 P00352 2/20 0.36
KCNQ4 P56696 3/20 0.36
KCNQ5 Q9NR82 3/20 0.36
POLQ O75417 1/20 0.36
HDAC2 Q92769 1/20 0.36
MEN1 O00255 1/20 0.36
HTT P42858 1/20 0.36
PIK3CD O00329 1/20 0.35
ABL1 P00519 1/20 0.35
EGFR P00533 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7138096 0.88 AAK1 (0.43) AAK1ABCB1ABCC1SMN1; SMN2CYP1A2
SCHEMBL7143512 0.85 AAK1 (0.45) AAK1ABCB1ABCC1SMN1; SMN2HDAC1
SCHEMBL7138568 0.83 ABCB1 (0.41) ABCB1ABCC1MAPTKMT2AALDH1A1
SCHEMBL7143058 0.82 AAK1 (0.44) AAK1ABCB1ABCC1SMN1; SMN2HDAC1
SCHEMBL7141564 0.81 HDAC2 (0.45) AAK1HDAC1KCNQ4KCNQ5HDAC2
SCHEMBL7147120 0.79 AAK1 (0.37) AAK1HDAC1MAPTKMT2AKCNQ4
SCHEMBL25380050 0.79 AAK1 (0.47) AAK1ABCB1ABCC1ALDH1A1PIK3CD
SCHEMBL6313426 0.78 RXFP1 (0.44) MAPTKMT2AALDH1A1KCNQ4KCNQ5
SCHEMBL826795 0.77 HDAC1 (0.50) AAK1HDAC1KCNQ4KCNQ5HDAC2
SCHEMBL197145 0.77 HDAC1 (0.55) AAK1HDAC1KCNQ4KCNQ5HDAC2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1224174-B1 BENZODIAZEPINE DERIVATIVES AS METABOTROPIC GLUTAMATE RECEPTOR ANTAGONISTS HOFFMANN LA ROCHE (CH) 2003-09-17 EP disclosed
EP-1224174-A2 BENZODIAZEPINE DERIVATIVES AS METABOTROPIC GLUTAMATE RECEPTOR ANTAGONISTS F. HOFFMANN-LA ROCHE AG (CH) 2002-07-24 EP disclosed
US-6407094-B1 4-5-DIDEHYDRO-1,5-BENZODIAZEPIN-2-ONE DERIVATIVES; PSYCHOLOGICAL, NERVOUS SYSTEM, AND BRAIN DISORDERS; COGNITION ACTIVATORS; ALZHEIMER*S DISEASE, SCHIZOPHRENIA HOFFMANN-LA ROCHE INC. 2002-06-18 US disclosed
WO-2001029011-A2 BENZODIAZEPINE DERIVATIVES AS METABOTROPIC GLUTAMATE RECEPTOR ANTAGONISTS F. HOFFMANN-LA ROCHE AG (CH) 2001-04-26 WO disclosed